2016
DOI: 10.11138/gchir/2016.37.2.055
|View full text |Cite
|
Sign up to set email alerts
|

Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas

Abstract: About urology pertinent neuroendocrine tumors, the literature has been enriched, in the last decade, with intriguing contributions concerning the urinary tract sympathetic paragangliomas, particularly renal pelvis, bladder, prostate or periprostatic locations. ParagangliomasParagangliomas,as neuroendocrine tumors arising from embryonic neural crest cells of either sympathetic or parasympathetic paraganglia -groups of cells near nervous system-derived respective ganglia -may be of two types, functional (sympath… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“… 3 Sympathetic paragangliomas of the kidney are extremely rare and the mechanism by which they develop in the kidney is unknown. 4 The may occur in the hilum (32%), upper pole (26%) or lower pole (42%) of the kidney. 5 …”
Section: Discussionmentioning
confidence: 99%
“… 3 Sympathetic paragangliomas of the kidney are extremely rare and the mechanism by which they develop in the kidney is unknown. 4 The may occur in the hilum (32%), upper pole (26%) or lower pole (42%) of the kidney. 5 …”
Section: Discussionmentioning
confidence: 99%
“…The first case of urinary bladder paraganglioma was reported in 1953 by Zimmerman et al [77]. Bladder paragangliomas account for 0.05-0.1% of all bladder tumors and 6% of paragangliomas [78,79]. Females are three times more commonly affected than males [80].…”
Section: Epidemiology Presentation and Pathogenesismentioning
confidence: 99%
“…The tumor can be contracted through transurethral or open/laparoscopic radical or partial cystectomy in conjunction with lymph node dissection [78,99]. Adjuvant radiation therapy can provide better survival for individuals enduring malignant tumors [79]. Table 6.…”
Section: Prognosis and Managementmentioning
confidence: 99%